joimax(R) Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis

KARLSRUHE, Germany, June 3 The joimax(R) company inKarlsruhe, Germany, is the first company in the medical industry whichdeveloped a unique instrumentation for the treatment of spinal canalstenosis. Having this degenerative disease at the spinal column, bonyexcrescences (osteophytes) narrow the spinal canal and drastically limit themotoric and sensoric function of the affected person. The so called 360degree TESSYS(TM) Spinal Stenosis System, which has been realized incooperation with Dr. Rudolf Morgenstern, Barcelona, Spain (Centro Medico deTerapia de la Columna), enables surgeons to completely remove thisosseous/bony material under direct endoscopic view through the vertebralforamen. Especially relating to elderly people in industrialised countries,spinal canal stenosis is a frequent growing disease of the spine. So far,affected patients are operated, if possible, with the open microsurgicalmethod under full anaesthesia - however, this causes bigger tissue damage andmay result in instability of the spinal column. "With our new method thepatient is under local anaesthetics and via a fingernail-like cut the minimalaccess to the stenosis is enabled. Surrounding tissue is hardly damaged andthanks to new endoscopic reamers and chisels allowing removal of osteophytes,treated patients can leave the hospital only a few hours after the surgery",explains Dr. Rudolf Morgenstern.

A further product innovation revolutionizing spinal surgery is the socalled iLESSYS(TM) - interLaminar Endoscopic Surgical System. It enables thefully dorsal endoscopic access to the lamina and to the spinal canal, whichin a stenotic patient situation is heavily compressing all structures. "WithiLESSYS(TM) and together with the TESSYS(TM) Stenosis System a full 360degree spinal canal treatment offering is now made available for tissue, butif indicated, also for bony decompression procedures," summarizes WolfgangRies, founder and CEO of the joimax(R) GmbH.

Both new instrumentations are based on the TESSYS(TM) - TransforaminalEndoscopic Surgical System, an operation technique and method which is usedworldwide for the removal of lumbar disc herniations. Surgeons are regularlyoffered the opportunity to familiarize themselves with this sophisticatedplatform technology by using the instruments in hands-on sessions, and at thesame time exchange experiences with their peers. For example, during theSpineweek, Geneva, Switzerland, May 27th - 31st 2008, at which joimax(R) hadorganized a lunch symposium and showed good presence at the industrialexhibition. Further events with joimax(R) are:

DGNC - 59th Annual Conference of the German Society for Neurosurgery,held June, 1st - 4th 2008 in Wurzburg, Germany: joimax(R) is represented witha booth exhibition and is again organising a Lunch-Symposium for TESSYS(TM).

Additionally at The 1st WCMISST - World Congress of Minimally InvasiveSpine Surgery & Techniques, June, 3rd -7th 2008 in Honolulu, Hawaii: Herejoimax(R) offers Cadaver Workshops on June 3rd and 4th, besides presentingits latest new products at the industrial exhibition.

Another next innovation of the joimax(R) product portfolio is the VideoTWISTER, a unique electronic device enabling a 360 degree video rotationcontinuously adjustable. Additionally, a zoom in magnification and an imagecentring function are made available.

About joimax(R): The young medical devices company is focusing oncombined minimal access technologies ("joined minimal access technologies"),especially for spinal treatment. As a unique player, joimax(R) develops,manufactures and markets highly sophisticated and user friendly platformsystems for endoscopic spinal surgery, which are evolving by experience andwhich are well evaluated to succeed. Due to education and multi-year businessexperience of its employees, joimax(R) has gained core competencies inmedical devices, systems, hard- and softwa

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...